Mesoblast (MESO) Income from Continuing Operations (2014 - 2023)
Mesoblast (MESO) reported Income from Continuing Operations of -$56.27 million for the year ended Jun 30, 2026, compared with -$101.48 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Income from Continuing Operations (2014 - 2023) Analysis & Trends
Dating back to the year ended Jun 30, 2015, Mesoblast's Income from Continuing Operations record includes 12 years.
- The figure for the year ended Jun 30, 2026 ranks as the highest annual Income from Continuing Operations in data going back to the year ended Jun 30, 2015.
- According to Business Quant data, Income from Continuing Operations came in at -$101.48 million in the year ended Jun 30, 2025, -$88.34 million in the year ended Jun 30, 2024, -$82.31 million in the year ended Jun 30, 2023 and -$91.83 million in the year ended Jun 30, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Mesoblast | 1.84 Bn | 1.40 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -21.92 Mn |
| Mar 31, 2023 | -18.60 Mn |
| Dec 31, 2022 | -24.49 Mn |
| Sep 30, 2022 | -16.88 Mn |
| Jun 30, 2022 | -21.46 Mn |
| Mar 31, 2022 | -21.30 Mn |
| Dec 31, 2021 | -25.95 Mn |
| Sep 30, 2021 | -22.65 Mn |
| Jun 30, 2021 | -22.06 Mn |
| Mar 31, 2021 | -26.52 Mn |
| Dec 31, 2020 | -25.69 Mn |
| Sep 30, 2020 | -24.54 Mn |
| Jun 30, 2020 | -32.61 Mn |
| Mar 31, 2020 | -15.26 Mn |
| Dec 31, 2019 | -24.58 Mn |
| Sep 30, 2019 | -5.48 Mn |
| Jun 30, 2019 | -20.73 Mn |
| Mar 31, 2019 | -24.97 Mn |
| Dec 31, 2018 | -24.60 Mn |
| Sep 30, 2018 | -19.50 Mn |
API Access
Mesoblast Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();